Diagnos Laboratorium Utama PT Tbk (DGNS) — Cash Flow-to-Debt Ratio
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of Rp1.52 Billion could theoretically repay 0% of its total liabilities (Rp110.07 Billion) in one year. Check how aggressively does Diagnos Laboratorium Utama PT Tbk reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Diagnos Laboratorium Utama PT Tbk Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Diagnos Laboratorium Utama PT Tbk across 8 annual periods. Also explore Diagnos Laboratorium Utama PT Tbk asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Diagnos Laboratorium Utama PT Tbk (2017–2024)
Year-by-year debt coverage analysis for Diagnos Laboratorium Utama PT Tbk. For market capitalisation and broader financial context, see DGNS stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (IDR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | Rp27.30 Billion | Rp103.89 Billion | ▲ +51.2% |
| 2023 | 0.17x | Rp13.18 Billion | Rp75.88 Billion | ▲ +185.2% |
| 2022 | -0.20x | Rp-6.02 Billion | Rp29.51 Billion | ▼ -113.9% |
| 2021 | 1.47x | Rp58.87 Billion | Rp40.18 Billion | ▲ +87.2% |
| 2020 | 0.78x | Rp26.23 Billion | Rp33.51 Billion | ▼ -10.8% |
| 2019 | 0.88x | Rp11.20 Billion | Rp12.76 Billion | ▲ +15.7% |
| 2018 | 0.76x | Rp8.47 Billion | Rp11.17 Billion | ▲ +661.0% |
| 2017 | -0.14x | Rp-712.00 Million | Rp5.27 Billion | — |